Back to Directory

Barbara Heckman

Email

bheckman@frontierscience.org

Phone

716-834-0900 Ext.7231

Institution

Frontier Science and Technology Research Foundation (FSTRF)

Address

Frontier Science & Technology Research Foundation, Inc.
4033 Maple Road
Amherst, NY 14226-1056
United States of America

Request an Update

Affiliated Studies

P1093: PK, Safety, Tolerability and Antiviral Activity of Dolutegravir

DAIDS Number

Research Area

IMPAACT 2020: Phase II Study of Shortened Oral Treatment for Rifampicin-Resistant Tuberculosis in Children

DAIDS Number

Research Area

Study Status

IMPAACT 2042: Tatelo Plus

DAIDS Number

Research Area

Cure and Immunotherapy

Study Status

IMPAACT 2034: Phase 1 Study of the Pharmacokinetics, Safety, and Acceptability of a Single Dose of Pretomanid Added to an Optimized Background Regimen in Children with Rifampicin-Resistant Tuberculosis

DAIDS Number

Research Area

Study Status

IMPAACT 2036: Phase I/II Study of the Safety, Tolerability, Acceptability, and Pharmacokinetics of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living with HIV-1, Two to Less Than 12 Years of Age

DAIDS Number

Research Area

Study Status

Show All